All Cases

Portfolio and Early Stage

Evaluated Ischemic Heart Failure Commercial Opportunity to Guide Portfolio Investment Decisions at a Mid-Size Biotech

Business development scan and prioritization of potential Rheumatology assets for acquisition or in-licensing

Indication prioritization for an early-stage oncology asset

Fast-to-market opportunity assessment of an orphan disease with a pipeline oncology drug

Lifecycle planning for a pipeline solid cancer therapy asset

Biomarker and combination assessment to define a data generation for a Prostate Cancer asset

Defined business unit and opportunity prioritization to expand the Brain Cancer portfolio of a large manufacturer

Evaluated 10 potential indications for a clinical-stage Biotech seeking to prioritize the clinical path to market and potential return of two assets

Glaucoma Portfolio Optimization for a Large Pharmaceutical Company to Unlock Brand Synergies After Recent Acquisitions

Pediatric Ophthalmology market landscape assessment to identify potential portfolio opportunities